Fullerene inhibits β-amyloid peptide aggregation
- 15 March 2003
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 303 (2), 576-579
- https://doi.org/10.1016/s0006-291x(03)00393-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Inhibition of Alzheimer's disease β‐amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapyThe FASEB Journal, 2001
- Solubility of C60 FullereneThe Journal of Physical Chemistry B, 2001
- C60 Carboxyfullerene Exerts a Protective Activity against Oxidative Stress-Induced Apoptosis in Human Peripheral Blood Mononuclear CellsBiochemical and Biophysical Research Communications, 2000
- Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerizationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Blockage of apoptotic signaling of transforming growth factor‐β in human hepatoma cells by carboxyfullereneEuropean Journal of Biochemistry, 1998
- Selective Inhibition of Aβ Fibril FormationJournal of Biological Chemistry, 1996
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991